A Practical Guide to Using Biologics in Pediatric Dermatology

Psoriasis, hidradenitis suppurativa (HS), atopic dermatitis (AD), and chronic spontaneous urticaria (CSU), are common, immune-mediated, chronic, inflammatory skin diseases that can affect the pediatric population. While there is adequate evidence supporting the use of biologics in pediatric patients...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of Cutaneous Medicine and Surgery Vol. 28; no. 1; pp. 59 - 67
Main Authors:	George, Annie, Lansang, Rafael Paolo, Lansang, Perla, Gooderham, Melinda
Format:	Book Review Journal Article
Language:	English
Published:	Los Angeles, CA SAGE Publications 01-01-2024 SAGE PUBLICATIONS, INC
Subjects:	Review atopic dermatitis hidradenitis suppurativa biologics chronic spontaneous urticaria psoriasis pediatrics
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Psoriasis, hidradenitis suppurativa (HS), atopic dermatitis (AD), and chronic spontaneous urticaria (CSU), are common, immune-mediated, chronic, inflammatory skin diseases that can affect the pediatric population. While there is adequate evidence supporting the use of biologics in pediatric patients, concerns regarding safety and efficacy amongst healthcare providers are not uncommon. However, new emerging evidence in this population highlights the safety of biologic therapy, making it crucial to review and establish a practical guide for their use. This article describes a methodological framework for initiating biologics in the management of pediatric psoriasis, HS, AD, and CSU, with a special focus on baseline work-up, monitoring, dosing, and considerations in this population.
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1
ISSN:	1203-4754 1615-7109
DOI:	10.1177/12034754231222415